<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00006516</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-0115</org_study_id>
    <secondary_id>1R01HD038600-01</secondary_id>
    <nct_id>NCT00006516</nct_id>
  </id_info>
  <brief_title>Home Stimulation for Brain-Asphyxiated Infants</brief_title>
  <official_title>Neuroplasticity of Brain-Asphyxiated Infants: Efficacy of Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <brief_summary>
    <textblock>
      This study examines the potential benefits of a home stimulation program to treat infants who&#xD;
      have suffered from brain asphyxiation (lack of oxygen). The program involves one year of&#xD;
      stimulatory activities. Progress will be evaluated through neurological and behavioral exams.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although the incidence of brain injury in infants is only 2 to 5 per 1000 births, the legal&#xD;
      and medical costs, the developmental delays, and the impact on the family are profound.&#xD;
      Twenty to 30% of survivors of brain injury have some long-term neurologic sequelae.&#xD;
&#xD;
      This randomized controlled trial will enroll 120 term and near-term neonates with a history&#xD;
      of asphyxia to 1-year of a standard follow-up program (provided by the Los Angeles Regional&#xD;
      Centers) or a home-based intervention program (Utah State University's Developmental&#xD;
      Curriculum and Monitoring System, CAMS). The experimental intervention will include&#xD;
      individualized cognitive/neuromotor stimulation given by the child's parents under the&#xD;
      guidance of public health nurses. Following the intervention, measures will be used to&#xD;
      determine functional capacity (Bayley II scale and neurologic examination), behavioral&#xD;
      outcomes (HOME and NCAST by developmental specialists), and maternal outcomes (including&#xD;
      parent-infant interaction and perceived stress). Infants will be assessed after the 1-year&#xD;
      intervention by psychologists and physicians masked to the intervention. Functional MRI brain&#xD;
      studies will be conducted at discharge and 18 months of age at UCLA to assess qualitative and&#xD;
      quantitative sensorimotor representation. Secondary outcomes include care stress and social&#xD;
      support as reported by parents, and demographics and medical factors obtained from the&#xD;
      hospital records.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1999</start_date>
  <primary_completion_date type="Actual">August 2004</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hypoxia, Brain</condition>
  <condition>Hypoxia-Ischemia, Brain</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Infant stimulation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
        All of the following criteria must be met:&#xD;
&#xD;
          -  Gestation age (GA) at birth &gt;= 28 weeks&#xD;
&#xD;
          -  Discharged to home care with parent or other guardian who has legal authority to give&#xD;
             informed consent&#xD;
&#xD;
          -  Greater than 10th percentile for GA at birth using the scales according to Lubchenco,&#xD;
             Hansman, and Boyd from Pediatrics 1966 volume 37 and Battaglia and Lubchenco in the&#xD;
             Journal of Pediatrics 1967 volume 71&#xD;
&#xD;
          -  Jewelry in pierced body parts can be removed&#xD;
&#xD;
          -  Mothers &gt; 17 years old&#xD;
&#xD;
          -  Recruited within 60 days of EDC (estimated date of conception)&#xD;
&#xD;
        Two or more of the following must be met:&#xD;
&#xD;
          -  Intrapartum distress as determined by placental abruption, thick meconium staining of&#xD;
             amniotic fluid, sustained fetal bradycardia of heart rate &lt; 100 beats/min, or late or&#xD;
             absent heart rate variability&#xD;
&#xD;
          -  Profound metabolic or mixed academia as determined by umbilical artery pH &lt; 7.0, base&#xD;
             deficit of &gt; 10 mEq/L or pH &lt; 7.1 and base excess greater than 14 mmol/L within 72&#xD;
             hours of birth, Apgar score &lt; 5 at 5 minutes or beyond, or need for positive pressure&#xD;
             ventilation resuscitation for &gt; 1 min after birth&#xD;
&#xD;
          -  Neonatal neurological manifestations such as seizures during hospital stay, lethargy,&#xD;
             hypotonia or hypertonia, stupor, flaccidity, or decerebration&#xD;
&#xD;
          -  Multiple organ system dysfunction&#xD;
&#xD;
          -  Abnormal EEG, CT scan, or MRI consistent with hypoxic or ischemic brain insult&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infants of substance abusing mothers (ISAM)&#xD;
&#xD;
          -  Intrauterine growth retardation (IUGR)&#xD;
&#xD;
          -  Infants requiring extracorporeal membrane oxygenation (ECMO) in the neonatal period&#xD;
&#xD;
          -  Hearing or visual impairment&#xD;
&#xD;
          -  Congenital cyanotic heart disease with cyanosis and requiring PGE infusion. Children&#xD;
             with minimum cardiac structural anomalies (e.g., PDA or VSD or peripheral pulmonary&#xD;
             stenosis) will not be excluded from the study.&#xD;
&#xD;
          -  Congenital abnormalities of the central nervous system such as congenital&#xD;
             hydrocephalus&#xD;
&#xD;
          -  Grade IV intraventicular hemorrhage requiring ventriculo-peritoneal shunt (VP shunt)&#xD;
&#xD;
          -  Trisomy 13, 18, or 21, or Fragile X&#xD;
&#xD;
          -  Metabolic encephalopathy from inborn errors of metabolism (e.g. PKU, OTC)&#xD;
&#xD;
          -  Metal or wire mesh implants, pacemaker implants, cochlear implants, orthopedic&#xD;
             surgical wires or implants&#xD;
&#xD;
          -  Status epilepticus&#xD;
&#xD;
          -  Ventilator dependent at discharge&#xD;
&#xD;
          -  Infectious meningitis&#xD;
&#xD;
          -  Encephalitis with radiological evidence of severe cortical or severe hemispheric&#xD;
             destruction&#xD;
&#xD;
          -  Silastic catheters, broviacs, or Hickman port home TPA&#xD;
&#xD;
          -  Infants who may not be available for the duration of the study&#xD;
&#xD;
          -  Any infant who in the opinion of investigator has no potential to benefit from the&#xD;
             intervention (e.g., children with prenatal herpes meningitis, severe cortical&#xD;
             destruction, mother does not follow up with the intervention or with the follow-up&#xD;
             appointments)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meena Garg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California at Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California at Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <study_first_submitted>November 21, 2000</study_first_submitted>
  <study_first_submitted_qc>November 21, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2000</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <keyword>Neonatal brain injury</keyword>
  <keyword>Brain Hypoxia</keyword>
  <keyword>Cerebral Hypoxia</keyword>
  <keyword>Brain Hypoxia-Ischemia</keyword>
  <keyword>Brain Ischemia-Hypoxia</keyword>
  <keyword>Cerebral Hypoxia-Ischemia</keyword>
  <keyword>Cerebral Ischemia-Hypoxia</keyword>
  <keyword>Environmental enrichment</keyword>
  <keyword>Cognitive/sensorimotor stimulation</keyword>
  <keyword>Parent-infant interactions</keyword>
  <keyword>Prenatal hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

